GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EME · Mar 31, 2025

EMCOR Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000105634-25-000029General Corporate
Capex intensity95thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.68% · OPTIONAL · VALID

Operating cash generation20thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

2.80% · OPTIONAL · VALID

Revenue growth60thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

12.68% · CORE · VALID

Gross margin90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

18.69% · CORE · VALID

Operating margin85thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

8.24% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History41 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.51%
Current
0.68%
Delta
0.16%
Cash Generation Decreased
Previous
9.67%
Current
2.80%
Delta
-6.86%
Growth Decreased
Previous
15.76%
Current
12.68%
Delta
-3.08%
Margin Decreased
Previous
18.98%
Current
18.69%
Delta
-0.30%
Profitability Decreased
Previous
9.23%
Current
8.24%
Delta
-0.99%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.